Q3989474 (Q3989474): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Removed claims)
(‎Changed an Item: importing one item from Netherlands)
Property / instance of
 
Property / instance of: Kohesio project / rank
 
Normal rank
Property / financed by
 
Property / financed by: European Union / rank
 
Normal rank
Property / country
 
Property / country: Kingdom of the Netherlands / rank
 
Normal rank
Property / start time
 
1 January 2019
Timestamp+2019-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / start time: 1 January 2019 / rank
 
Normal rank
Property / start time
 
31 December 2021
Timestamp+2021-12-31T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / start time: 31 December 2021 / rank
 
Normal rank
Property / beneficiary name (string)
 
Caelus Pharmaceuticals B.V.
Property / beneficiary name (string): Caelus Pharmaceuticals B.V. / rank
 
Normal rank
Property / beneficiary
 
Property / beneficiary: Q3987337 / rank
 
Normal rank
Property / EU contribution
 
78,331.0 Euro
Amount78,331.0 Euro
UnitEuro
Property / EU contribution: 78,331.0 Euro / rank
 
Normal rank
Property / budget
 
391,654.0 Euro
Amount391,654.0 Euro
UnitEuro
Property / budget: 391,654.0 Euro / rank
 
Normal rank
Property / co-financing rate
 
20.0 percent
Amount20.0 percent
Unitpercent
Property / co-financing rate: 20.0 percent / rank
 
Normal rank
Property / fund
 
Property / fund: European Regional Development Fund / rank
 
Normal rank
Property / postal code
 
1105 BP
Property / postal code: 1105 BP / rank
 
Normal rank
Property / programme
 
Property / programme: West Netherlands - ERDF / rank
 
Normal rank
Property / intervention field
 
Property / intervention field: Technology transfer and university-enterprise cooperation primarily benefiting SMEs / rank
 
Normal rank

Revision as of 16:24, 13 December 2021

Project Q3989474 in Netherlands
Language Label Description Also known as
English
No label defined
Project Q3989474 in Netherlands

    Statements

    78,331.0 Euro
    0 references
    391,654.0 Euro
    0 references
    20.0 percent
    0 references
    1 January 2019
    0 references
    31 December 2021
    0 references
    Caelus Pharmaceuticals B.V.
    0 references
    0 references
    1105 BP
    0 references

    Identifiers

    OP-2014-2023-West-KVW-00211
    0 references